Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Barlow J, Blouin J, Blouin A (1988) Treatment of bulimia with desipramin. A double-blind cross-over study. Can J Psychiatry 330: 129–133
Beck AT (1976) Cognitive therapy and the emotional disorders. International Universities Press, New York
Berger AW, Yeager M, Welch R (2003) Candidate gene analysis of the Price Foundation anorexia nervosa affected relative pair dataset. Current drug targets. CNS Neurol Dis 2: 41–51
Blundell JE, Hill AJ (1987) Serotonergic modulation of the pattern of eating and the profile of hunger-satiety. Int J Obes 11: 141–155
Casper RC, Schlemmer RF, Javoid JI (1987) A placebo controlled crossover study of oral clonidine in acute anorexia nervosa. Psychiatry Res 20: 249–260
Casper RC, Schoeller DA, Kushner R, Hnilicka J, Gold ST (1991) Total daily energy expenditure and activity level in anorexia nervosa. Am J Clin Nutr 53: 1143–1150
Devlin MJ, Walsh BT, Kral JG, Heymsfield SB, Pi-Sunyer FX, Dantzic S (1990) Metabolic abnormalities in bulimia nervosa. Arch Gen Psychiatry 47: 144–148
Doerr P, Fichter MM, Pirke KM, Lund R (1980) Relationship between weight gain and hypothlamic pituitary adrenal function in patients with anorexia nervosa. J Steroid Biochem Mol Biol 13: 529–537
Fairburn CG, Cooper Z (1987) Behavioral and cognitive approaches to the treatment of anorexia nervosa and bulimia nervosa. In: Beumont PJV, Burrows GD, Casper RC (eds) Handbook of eating disorders, Part 1. Elsevier, Amsterdam, 271–298
Fichter MM, Pirke KM (1986) Effect of experimental and pathological weight loss upon the HPA axis. Psychoneuroendocrinology 11: 295–305
Fichter MM, Pirke KM, Pöllinger J, Wolfram G, Brunner E (1990) Disturbances in the hypothalamo-pituitary-adrenal and other neuroendocrine axes in bulimia. Biol Psychiatry 27: 1021–1037
Fichter MM, Leibl C, Brunner E, Schmidt-Auberger S, Engel RR (1990) Fluoxetine vs. placebo: a double-blind study with bulimic inpatients undergoing psychotherapy. Pharmacopsychiatry 24: 1–7
Garner DM, Bemis K (1985) Cognitive therapy for anorexia nervosa. In: Garner DM, Garfinkel RE (eds) Handbook of psychotherapy for anorexia nervosa and bulimia nervosa. Guilford, New York, pp 513–572
Gavish D, Eisenberg S, Berry EM, Kleinman Y, Witztum E, Norman J, Leistersdorf E (1987) An underlying behavioral disorder in hyperlipidemic pancreatitis: a prospective multidisciplinary approach. Arch Intern Med 147: 705–708
George DT, Kaye WH, Goldstein DS, Brewerton TD, Jimerson DC (1990) Altered norepinephrine regulation in bulimia: Effects of pharmacological challenge with isoprotenerol. Psychiatry Res 33: 1–10
Geracioti TD, Liddle RA (1988) Impaired cholecystokinin secretion in bulimia nervosa. N Engl J Med 11: 683–688
Gillberg IC, Gillberg C, Rastam M, Johansson M (1996) The cognitive profile of anorexia nervosa: a comparative study including a community-based sample. Compr Psychiatry 37(1): 23–30
Gold PW, Gwirtsman H, Avgerinos PC et al (1986) Abnormal hypothalamic-pituitary-adrenal function in anorexia nervosa. N Engl J Med 314: 1335–1342
Green MW, Elliman NA, Wakeling A, Rogers PJ (1996) Cognitive functioning, weight change and therapy in anorexia nervosa. J Psychiatr Res 30(5): 401–410
Gwirtsman H, Kaye WH, George DT, Jimerson DC, Ebert MH, Gold PW (1989) Central and peripheral ACTH and cortisol levels in anorexia nervosa and bulimia. Arch Gen Psychiatry 46: 61–69
Halmi KA, Eckert ED, LaDu TJ, Cohen J (1986) Anorexia nervosa. Treatment efficacy of cyproheptadine and amitryptiline. Arch Gen Psychiatry 43: 177–181
Hamsher KS, Halmi KA, Benton AL (1981) Prediction of outcome in anorexia nervosa from neuropsychological status. Psychiatry Res 4: 79–88
Hebebrand J, Blum WF, Barth N et al (1997) Leptin levels in patients with anorexia nervosa are reduced in the acute stage and elevated upon short-term weight restoration. Mol Psychiatry 2: 330–334
Heufelder A, Warnhoff M, Pirke KM (1985) Platelet α2-adrenoceptors and adenylate cyclase in patients with anorexia nervosa and bulimia. J Clin Endocrinol Metabol 61: 1053–1057
Holtkamp K, Herpertz-Dahlmann B, Mika C (2003) Elevated physical activity and low leptin levels in patients with anorexia nervosa. J Clin Endocrinol Metabol 88: 5169–5174
Hudson JI, Pope HG Jr, Jonas JM, Yurgelun-Todd D (1983) Family history of anorexia nervosa and bulimia. Br J Psychiatry 142: 133–138
Hughes PL, Wells LA, Cunningham CJ (1987) The dexamethasone suppression test in bulimia before and after successful treatment with desipramine. J Clin Psychiatry 47: 515–517
Kaplan A (1987) Thyroid function in bulimia. In: Hudson JI, Pope HG (eds) The psychobiology of bulimia. American Psychiatric Press, Washington, DC, pp 55–72
Kaye WH, Ebert MH, Raleigh M, Lake CR (1984a) Abnormalities in CNS monoamine metabolism in anorexia nervosa. Arch Gen Psychiatry 41: 350–355
Kaye WH, Gwirtsman HE, Ebert MH, Weiss S (1984b) Differences in brain serotonergic metabolism between nonbulimic and bulimic patients with anorexia nervosa. Am J Psychiatry 141: 1598–1601
Kaye WH, Gwirtsman HE, George DT, Jimerson DC, Ebert MH, Lake CR (1990) Disturbances of noradrenergic systems in normal weight bulimia: relationship to diet and menses. Biol Psychiatry 27: 4–17
Kaye WH, Klump KL, Frank GK (2000) Anorexia and bulimia nervosa. Annu Rev Med 51: 299–313
Keys A, Brozek J, Henschel A, Mickelson O, Taylor HL (1950) The biology of human starvation. University of Minnesota Press, Minneapolis
Kingston K, Szmukler G, Andrewes D, Tres B, Desmond P (1996) Neuropsychological and structural brain changes in anorexia nervosa before and after refeeding. Psychol Med 26: 15–28
Kiriike N, Nishiwaki S, Izumiya Y, Kawakita Y (1986) Dexamethasone suppression test in bulimia. Biol Psychiatry 21: 325–328
Köpp W, Blum WF, Prittwitz von S et al (1997) Low leptin levels predict amenorrhea in underweight and eating disordered females. Mol Psychiatry 2: 335–340
Kortegard LS (2001) A preliminary population-based twin study of sel-freported eating disorder. Psychol Med 31: 361–365
Krieg JC, Lauer C, Pirke KM (1989) Structural brain abnormalitis in patients with bulimia nervosa. Psychiatry Res 27: 39–48
Krieg JC, Lauer C, Leinsinger G, Pahl J, Schreiber W, Pirke KM, Moser EA (1989) Brain morphology and regional cerebral blood flow in anorexia nervosa. Biol Psychiatry 25: 1041–1048
Laessle RG, Krieg JC, Fichter MM, Pirke KM (1989) Cerebral atrophy and vigilance performance in patients with anorexia nervosa and bulimia nervosa. Neuropsychobiology 21: 187–191
Laessle RG, Beumont PJV, Butow P et al (1991) A comparison of nutritional management and stress management in the treatment of bulimia nervosa. Br J Psychiatry 159: 250–261
Laessle RG, Fischer M, Fichter MM, Pirke KM, Krieg JC (1992) Cortisol levels and vigilance in eating disorder patients. Psychoneuroendocrinology 17(5): 475–484
Lautenbacher S, Galfe G, Hölzl R, Pirke KM (1989) Gastrointestinal transit is delayed in patients with eating disorders. Int J Eating Dis 8: 203–208
Leibowitz SF (1984) Noradrenergic function in the medial hypothalamus. In: Pirke KM, Ploog D (eds) The psychobiology of anorexia nervosa. Springer, Berlin Heidelberg New York, pp 35–45
Levy AB, Dixon KN (1987) DST in bulimia without endogenous depression. Biol Psychiatry 22: 783–786
Lindy DC, Walsh BT, Roose SR, Gladis M, Glassman AH (1985) The dexamethasone suppression test in bulimia. Am J Psychiatry 142: 1375–1376
Mathias JL, Kent PS (1998) Neuropsychological consequences of extreme weight loss and dietary restriction in patients with anorexia nervosa. J Clin Exp Neuropsychol 20: 548–564
Mayerhausen W, Vogt HJ, Fichter MM, Stahl S (1990) Dermatologische Aspekte bei Anorexia und Bulimia nervosa. Hautarzt 41: 476–484
Mitchell JE, Pyle RL, Hatsukami D, Boutasoff CI (1984) The dexamethasone suppression test in patients with bulimia. J Clin Psychiatry 45: 508–511
Mitchell JE, Laine DE, Morley JE, Levine AS (1986) Naloxone but not CCK-8 may attenuate binge-eating behavior in patients with the bulimia syndromes. Biol Psychiatry 21: 1399–1406
Mortola JF, Rasmussen DD, Yen SSC (1989) Alterations of the adrenocorticotropin-cortisol axis in normal weight bulimic women: Evidence for a central mechanism. J Clin Endocrinol Metabol 68: 517–522
Mrosowski N (1984) Animal models: Anorexia yes, nervosa no. In: Pirke KM, Ploog D (eds) The psychobiology of anorexia nervosa. Springer, Berlin Heidelberg New York, pp 22–34
Musisi S, Garfinkel PE (1985) Comparative dexamethasone suppression test measurement in bulimia, depression and normal controls. Am J Psychiatry 30: 190–194
Philipp E, Pirke KM, Kellner MB, Krieg JC (1991) Disturbed cholecystokinin secretion in patients with eating disorders. Life Sci 48: 2443–2450
Pirke KM, Laessle RG (1993) Restrained eating. In: Stunkard AJ, Wadden T (eds) Obesity. Raven, New York, pp 151–162
Pirke KM, Ploog D (1986) The psychobiology of anorexia nervosa. In: Wurtman RJ, Wurtman JJ (eds) Nutrition and the brain. Raven, New York, pp 167–198
Pirke KM, Spyra B, Warnhoff M (1984) Effect of starvation on central neurotransmitter systems and on endocrine regulation. In: Pirke KM, Ploog D (eds) The psychobiology of anorexia nervosa. Springer, Berlin Heidelberg New York, pp 46–57
Pirke KM, Pahl J, Schweiger U, Warnhoff M (1985) Metabolic and endocrine indices of starvation in bulimia: A comparison with anorexia nervosa. Psychiatry Res 15: 33–39
Pirke KM, Fichter MM, Chlond C, Schweiger U, Laessle RG, Schwingenschloegel M, Hoehl C (1987) Disturbances of the menstrual cycle in bulimia nervosa. Clin Endocrinol 27: 245–251
Pirke KM, Riedel W, Tuschl R, Schweiger U, Spyra B (1988) Effect of standardized test meals on plasma norepinephrine in patients with anorexia nervosa and bulimia. Int J Eating Dis 7: 356–360
Pirke KM, Tuschl R, Spyra B (1990) Endocrine findings in restrained eaters. Physiol Behav 47: 903–906
Pirke KM, Trimborn P, Platte P, Fichter M (1991) Average total energy expenditure in anorexia nervosa, bulimia nervosa and healthy young women. Biol Psychiatry 30: 711–718
Pirke KM, Kellner M, Phillip E, Laessle RG, Krieg JC, Fichter MM (1992) Plasma norepinephrine after a standardized test meal in acute and remitted patients with anorexia nervosa and in healthy controls. Biol Psychiatry 31: 1074–1077
Platte P, Pirke KM, Trimborn P, Pietsch, K, Krieg JC, Fichter MM (1994) Resting metabolic rate and total energy expenditure in acute and weight recovered patients with anorexia nervosa and in healthy young women. Int J Eating Dis 16(1): 45–52
Sapolsky RM (2000) The possibility of neurotoxicity in the hippocampus in major depression: a primer on neuron death. Biol Psychiatry 48(8): 755–765
Schreiber W, Schweiger U, Werner D et al (1991) Circadian pattern of large neutral amino acids, glucose, insulin and food intake in anorexia nervosa and bulimia nervosa. Metabolism 40: 503–507
Schweiger U, Warnhhoff M, Pirke KM (1985) Brain tyrosin availability and the depression of central nervous norepinephrine turnover in acute and chronic starvation in adult male rats. Brain Res 335: 207–212
Schweiger U, Warnhhoff M, Pahl J, Pirke KM (1986) Effects of carbohydrate and protein meals on plasma large neutral amino acids, glucose, and insulin plasma levels of anorectic patients. Metabolism 35: 938–942
Schweiger U, Poellinger J, Laessle RG, Wolfram G, Fichter MM, Pirke KM (1987) Altered insulin response to a balanced test meal in bulimic patients. Int J Eating Dis 6: 551–556
Schweiger U, Pirke KM, Laessle RG, Fichter MM (1992) Gonadotropin secretion in bulimia nervosa. J Clin Endocrinol Metabol 74: 1122–1127
Seed JA, Dixon RA, McCluskey SE, Young AH (2000) Basal activity of the hypothalamic-pituitary-adrenal axis and cognitive function in anorexia nervosa. Eur Arch Psychiatry Clin Neurosci 250: 11–15
Silver AJ, Morley JE (1991) Role of CCK in regulation of food intake. Progr Neurobiol 36: 23–34
Small A, Madero J, Teagno L, Ebert M (1983) Intellect, perceptual characteristics and weight gain in anorexia nervosa. J Clin Psychol 39: 780–802
Smith GP, Gibbs J (1987) The satiety effect of cholecystokinin. Ann NY Acad Sci 48: 417–423
Stricker EM, Anderson AE (1980) The lateral hypothalamic syndrome. Life Sci 26: 1927–1934
Strober M, Freeman R, Lampert C (2000) Controlled family study of anorexia nervosa and bulimia nervosa. Am J Psychiatry 157: 393–401
Szmukler GI, Andrews D, Kingston K, Chen L (1992) Neuropsychological impairment in anorexia nervosa: Before and after refeeding. J Clin Exp Psychol 14(2): 347–352
Van Praag HM (1986) Monoamines and depression. In: Plunchik RI, Kellerman H (eds) Emotion. Academic Press, Orlando, pp 335–349
Waadt S, Laessle RG, Pirke KM (1992) Bulimie: Ursachen und Therapie. Springer, Berlin Heidelberg New York
Walsh BT (1989) Use of antidepressants in bulimia. Clin Pediatr 3: 127–128
Walsh BT, Roose SP, Katz JL, Dyrenforth I, Wright L, Vande Wiele R, Glassman AH (1989) Hypothalamic-pituitary-adrenal-cortical activity in anorexia nervosa and bulimia. Psychoneuroendocrinology 12: 131–140
Wilckens T, Schweiger K, Pirke KM (1992) Activation of α2-adrenoreceptors suppresses excessive wheel running in the semistarvation-induced hyperactive rat. Pharmacol Biochem Behav 43: 733–738
Willershausen B, Phillip E, Pirke KM, Fichter MM (1990) Orale Komplikationen bei Patienten mit Anorexia nervosa und Bulimia nervosa. Zahn-Mund-Kieferheilkunde 78: 293–299
Wurtmann RJ (1983) Behavioral effect of nutrients. Lancet 1: 1145–1150
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer Medizin Verlag Heidelberg
About this chapter
Cite this chapter
Laessle, R.G., Pirke, K.M. (2006). Essstörungen. In: Förstl, H., Hautzinger, M., Roth, G. (eds) Neurobiologie psychischer Störungen. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-30887-3_19
Download citation
DOI: https://doi.org/10.1007/3-540-30887-3_19
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-25694-6
Online ISBN: 978-3-540-30887-4
eBook Packages: Medicine (German Language)